Phase I study of an AI-designed oral formulation sets a new standard in drug developmentNOTTINGHAM, England, May 28, 2026 /PRNewswire/ -- Quotient Sciences today announces the successful initiation ...
Quotient Sciences initiates AI-designed drug product to guide formulation design and accelerate drug development: Nottingham, UK Saturday, May 30, 2026, 18:00 Hrs [IST] Quotient S ...
ZNetwork on MSNOpinion
AI, industrial sovereignty and Pax Silica
The United States, along with 14 other high-tech countries, established Pax Silica in December 2025 as a “strategic ...
7dOpinion
Narrative that ‘AI is like a child’ dangerously obscures technology’s real-world implications
Such framing depoliticises AI and displaces attention from profit-focused decisions and corporate accountability for the ...
Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...
Felix interviewed four Imperial students and researchers to dive into the motivations, hurdles and breakthroughs that drive ...
The emergence of large language models (LLMs) offers transformative potential for medical research. Current approaches often focus on LLMs as a replacement for researchers or as a supporting tool. In ...
In this blog we’ll cover the three new capability areas, now available on the Rescale Platform: Agentic Digital Engineering – Simulation-native prebuilt agents automate manual tasks like configuration ...
Abstract: Brain tumors rank among the most lethal forms of cancer, and their early detection is crucial for improving patient outcomes. Beyond timely identification, accurately determining tumor type ...
Abstract: Student learning effectiveness relies not only on the time dedicated to studying but also on how students regulate their cognitive effort, respond to task complexity, and manage academic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results